Tiziana Life Sciences announced the appointment of Professor Roberto Pellicciari to the company's Scientific Advisory Board and as a consultant to the company. Professor Pellicciari was the co-founder and remains Head of Medicinal Chemistry at Intercept Pharmaceuticals Inc. Professor Pellicciari is presently Professor of Medicinal Chemistry at the University of Perugia in Italy and has held a number of prestigious scientific posts.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9999 USD | +6.37% | +23.46% | +78.55% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+78.55% | 100M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Appoints Roberto Pellicciari to the Scientific Advisory Board